Literature DB >> 6180140

When is there a full recovery for a myasthenia gravis patient?

C Scoppetta, E Bartoccioni, P David, G Flamini, M Lo Monaco, F Scuderi, P Tonali.   

Abstract

A myasthenia gravis (MG) patient who seems to have recovered can later have recurrence of myasthenic signs. Clearly clinical remission does not always correspond to the normalization of all the factors involved in the pathogenesis of the disease. In ten patients who had apparently recovered from MG, electromyographic tests of repetitive supramaximal stimulation were performed and the anti-acetylcholine receptor (anti-AChR) antibody was assessed. In two of the ten patients all these tests were normal, thus showing lack of electromyographic myasthenic fatigability and the absence of circulating anti-AChR antibodies. Our hypothesis is that for these two subjects the risk of a recurrence of MG is lower than for the others.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6180140     DOI: 10.1007/bf00313771

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  17 in total

1.  Studies in myasthenia gravis: early thymectomy. Electrophysiologic and pathologic correlations.

Authors:  G Genkins; A E Papatestas; S H Horowitz; P Kornfield
Journal:  Am J Med       Date:  1975-04       Impact factor: 4.965

2.  The results to be expected from electrical testing in the diagnosis of myasthenia gravis.

Authors:  C Ozdemir; R R Young
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

3.  Myasthenia gravis, thymectomy and T-cells.

Authors:  C Scoppetta; I Burrai; P Tonali; L Russo
Journal:  Neurology       Date:  1979-03       Impact factor: 9.910

4.  Letter: Rosette tests following thymectomy.

Authors:  G P Sandilands; K Gray; A Cooney; J R Anderson; J A Simpson; P O Behan
Journal:  Lancet       Date:  1975-01-18       Impact factor: 79.321

5.  Treatment of myasthenia gravis. Report on 139 patients.

Authors:  C Scoppetta; P Tonali; A Evoli; P David; F Crucitti; M L Vaccario
Journal:  J Neurol       Date:  1979       Impact factor: 4.849

6.  The value of thymectomy in myasthenia gravis: a computer-assisted matched study.

Authors:  J M Buckingham; F M Howard; P E Bernatz; W S Payne; E G Harrison; P C O'Brien; L H Weiland
Journal:  Ann Surg       Date:  1976-10       Impact factor: 12.969

7.  Subpopulations of T lymphocytes in myasthenia gravis patients.

Authors:  M Piantelli; L Lauriola; A Carbone; A Evoli; P Tonali; P Musiani
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

8.  Myasthenia gravis in infancy.

Authors:  M E Seybold; J M Lindstrom
Journal:  Neurology       Date:  1981-04       Impact factor: 9.910

9.  Myasthenia gravis, thymectomy, and antiacetycholine receptor antibody.

Authors:  E Bartoccioni; F Scuderi; C Scoppetta; A Evoli; P Tonali; L Guidi; C Bartoloni; T Terranova
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

10.  Studies in myasthenia gravis: effects of thymectomy. Results on 185 patients with nonthymomatous and thymomatous myasthenia gravis, 1941-1969.

Authors:  A E Papatestas; L I Alpert; K E Osserman; R S Osserman; A E Kark
Journal:  Am J Med       Date:  1971-04       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.